fbpx Skip to main content

Member's Profile

Capricor Therapeutics

Location
8840 Wilshire Boulevard 2nd Floor
Beverly Hills,   California
90211
United States
Sector
Biotech
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Capricor Therapeutics
Biotech Company
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of transformative cell and exosomes-based therapeutics for the treatment and prevention of a broad spectrum of diseases. Capricor’s lead candidate, CAP-1002, is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy. Capricor has also established itself as one of the leading companies investigating the field of extracellular vesicles and is exploring the potential of CAP-2003, a cell-free, exosome-based candidate, to treat a variety of disorders.
Related News
No related news posted by this Member